The Charcot-Marie-Tooth Association (CMTA) congratulates CMTA Strategy To Accelerate Research (CMTA-STAR) Alliance Partner Applied Therapeutics...
CMTA-INC Alliance Announces 2025 Inherited Neuropathies Fellowship Recipient
The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research, today announced...
CMTA-INC Alliance Announces 2025 Inherited Neuropathies Fellowship Recipient: Orthopedic Surgeon to Focus on Improving Outcomes for People with CMT
The CMTA–INC Alliance announced the 2025 Inherited Neuropathies Fellowship recipient, supporting clinical research focused on corrective foot and ankle care and surgical outcomes for people with CMT.
CMTA Announces New Center of Excellence in Cincinnati
The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research, is...
Could MRI Help Speed Up CMT1A Research? New Findings from Professor Mary M. Reilly, MBE
A newly published study led by CMTA’s Strategy to Accelerate Research (CMTA-STAR) Clinical Expert Board...
CMTA Announces New Center of Excellence in Canada
The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research, is...
CMTA Invests $210K in Long-Read Sequencing to Accelerate CMT Gene Discovery
CMTA is investing $210,000 in long-read sequencing to uncover hidden gene mutations in undiagnosed CMT cases and improve access to diagnosis and future treatments.
CMTA Invests $210K in Long-Read Sequencing to Accelerate CMT Gene Discovery
Today, the Charcot-Marie-Tooth Association (CMTA) announced a $210,000 investment to advance gene discovery and improve...
CMT2F Study Achieves Recruitment Goal, Expands to Include Additional Participants
An international team of researchers from the Inherited Neuropathies Consortium (INC), led by CMTA’s Strategy...
CMTA Announces Its First Center of Excellence in Scotland
The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research, is...
